Page 12 - WNS 2022 PUBLICATION 5.5 X 8.5 - Text 4,25 X 7.5 incl. page number

Statement:
Before the program, anyone in control of the educational content of this
activity will disclose the existence of any financial interest and/or the
relationship they or their significant other have with the manufacturer(s)
of any commercial product(s) to be discussed during their presentation.
Disclosures will be included in the final program.
Speakers, paper presenters/authors and staff (and the significant others
of those mentioned) who have disclosed a relationship* with commer-
cial interests whose products may have a relevance to their presen-
tation are listed below.

NAME DISCLOSURE TYPE OF RELATIONSHIP

Juan Fernandez-
Miranda
Samer Ghostine, MD

Leucadia Therapeutics (CMO,Research support, Stock)

Avail, Cerenovus, Medtronic, Stryker (Consultant)
Baxter (Consultant); Brainlab, Stryker (Industry Grant)
Speakers, paper presenters/authors and staff (and the significant
others of those mentioned) who have reported they do not have
any relationships with commercial interests:
Moustapha Abou-Samra Barbara Lazio David Pitkethly* Mark Sedrak
Karol Budohoski Jay Morgan* Mara Pitkethly David Westra
Justin Dye* Nigel Nicholson J. Adair Prall Benjamin Yim
Ciara Harraher* John O'Meara Donald Prolo* Jacob Young
Won Kim Arjun Pendharkar Laura Prolo

12